Latest Findings on MicroRNAs in Diabetic Chronic Wounds

FANG Yi-xuan, CHEN Li-hong, LI Yan, RAN Xing-wu

Abstract

Diabetic chronic wound is one of the most serious complications of diabetes, imposing enormous socioeconomic burdens on diabetic patients, their families, and society due to its refractory nature. MicroRNAs (miRNAs) have emerged as important regulators of various physiological and pathological processes. Abnormalities arise in the regulatory functions of miRNAs in chronic diabetic wounds. Therefore, the modification of miRNAs expression in diabetic wounds is an important channel for the improvement of wound healing. The clinical translation of miRNA-based therapy may become a prospective direction of diabetic wound healing. However, miRNA-based therapy is still in its early stage of development, and actual translation into clinical application will take a long time. Herein, we summarized the latest research findings on miRNAs in diabetic chronic wounds healing.

 

Keywords: MicroRNAs, Diabetes, Wound healing

 

Full Text:

PDF


References


LIN C W， ARMSTRONG D G， LIN C H， et al. Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period. BMJ Open Diabetes Res Care， 2019， 7(1): e000795[2022-08-08]. https://doi.org/10.1136/bmjdrc-2019-000795.

CHEN L， SUN S， GAO Y， et al. Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies. Diabetes Obes Metab， 2022[2022-08-08]. https://doi.org/10.1111/dom.14840.

RODRIGUES M， KOSARIC N， BONHAM C A， et al. Wound healing: A cellular perspective. Physiol Rev，2019，99(1): 665–706.

TILI E， CROCE C M， MICHAILLE J J. miR-155: On the crosstalk between inflammation and cancer. Int Rev Immunol，2009，28(5): 264–284.

PARK H， HUANG X， LU C， et al. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem，2015，290(5): 2831–2841.

LI D， WANG A， LIU X， et al. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J Clin Invest，2015， 125(8): 3008–3026.

XIE J， WU W， ZHENG L， et al. Roles of microRNA-21 in skin wound healing: A comprehensive review . Front Pharmacol， 2022， 13: 828627[2022-08-08]. https://doi.org/10.3389/fphar.2022.828627.

FASANARO P， D'ALESSANDRA Y， DI STEFANO V， et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem，2008，283(23): 15878–15883.

NAMMIAN P， RAZBAN V， TABEI S M B， et al. MicroRNA-126: Dual role in angiogenesis dependent diseases. Curr Pharm Des，2020，26(38): 4883–4893.

CHEN Y， GORSKI D H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood，2008，111(3): 1217–1226.

OZDEMIR D， FEINBERG M W. MicroRNAs in diabetic wound healing: Pathophysiology and therapeutic opportunities. Trends Cardiovasc Med， 2019，29(3): 131–137.

YU J， PENG H， RUAN Q， et al. MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2. FASEB J，2010，24(10): 3950–3959.

WANG S Y， KIM H， KWAK G， et al. Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds. Theranostics，2020，10(7): 3240–3253.

SHI J， MA X， SU Y， et al. MiR-31 mediates inflammatory signaling to promote re-epithelialization during skin wound healing. J Invest Dermatol，2018，138(10): 2253–2263.

VITICCHIÈ G， LENA A M， CIANFARANI F， et al. MicroRNA-203 contributes to skin re-epithelialization. Cell Death Dis， 2012， 3(11): e435[2022-08-08].. https://doi.org/10.1038/cddis.2012.174.

GALLANT-BEHM C L， PIPER J， LYNCH J M， et al. A MicroRNA-29 mimic (remlarsen) represses extracellular matrix expression and fibroplasia in the skin. J Invest Dermatol，2019，139(5): 1073–1081.

ZHU Y， LI Z， WANG Y， et al. Overexpression of miR-29b reduces collagen biosynthesis by inhibiting heat shock protein 47 during skin wound healing. Transl Res， 2016， 178: 38−53.e6[2022-08-08]. https://doi. org/10.1016/j.trsl.2016.07.001.

BERTERO T， GASTALDI C， BOURGET-PONZIO I， et al. miR-483-3p controls proliferation in wounded epithelial cells. FASEB J，2011，25(9): 3092–3105.

LI X， LI D， WANG A， et al. MicroRNA-132 with therapeutic potential in chronic wounds. J Invest Dermatol，2017，137(12): 2630–2638.

BI X， ZHOU L， LIU Y， et al. MicroRNA-146a deficiency delays wound healing in normal and diabetic mice. Adv Wound Care (New Rochelle)， 2022，11(1): 19–27.

GONDALIYA P， SAYYED A A， BHAT P， et al. Mesenchymal stem cell-derived exosomes loaded with miR-155 inhibitor ameliorate diabetic wound healing. Mol Pharm，2022，19(5): 1294–1308.

LIECHTY C， HU J， ZHANG L， et al. Role of microRNA-21 and its underlying mechanisms in inflammatory responses in diabetic wounds. Int J Mol Sci，2020，21(9): 3328.

MADHYASTHA R， MADHYASTHA H， NAKAJIMA Y， et al. MicroRNA signature in diabetic wound healing: Promotive role of miR-21 in fibroblast migration. Int Wound J，2012，9(4): 355–361.

ZHANG J， SUN X J， CHEN J， et al. Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy. J Diabetes Complications，2017，31(1): 241–244.

ZHANG D， LI Z， WANG Z， et al. MicroRNA-126: A promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy. Diabetes Metab Syndr Obes，2019，12: 1685–1696.

LI M， KE Q F， TAO S C， et al. Fabrication of hydroxyapatite/chitosan composite hydrogels loaded with exosomes derived from miR-126-3p overexpressed synovial mesenchymal stem cells for diabetic chronic wound healing. J Mater Chem B，2016，4(42): 6830–6841.

ICLI B， NABZDYK C S， LUJAN-HERNANDEZ J， et al. Regulation of impaired angiogenesis in diabetic dermal wound healing by microRNA-26a. J Mol Cell Cardiol，2016，91: 151–159.

PICHU S， VIMALRAJ S， VISWANATHAN V. Impact of microRNA-210 on wound healing among the patients with diabetic foot ulcer. PLoS One， 2021， 16(7): e0254921[2022-08-08]. https://doi.org/10.1371/journal.pone.0254921.

BISWAS S， ROY S， BANERJEE J， et al. Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci U S A，2010，107(15): 6976–6981.

GHATAK S， LI J， CHAN Y C， et al. AntihypoxamiR functionalized gramicidin lipid nanoparticles rescue against ischemic memory improving cutaneous wound healing. Nanomedicine，2016，12(7): 1827–1831.

ZGHEIB C， HODGES M， HU J， et al. Mechanisms of mesenchymal stem cell correction of the impaired biomechanical properties of diabetic skin: The role of miR-29a. Wound Repair Regen，2016，24(2): 237–246.

PETKOVIC M， SØRENSEN A E， LEAL E C， et al. Mechanistic actions of microRNAs in diabetic wound healing. Cells，2020，9(10): 2228.

ZOGG H， SINGH R， RO S. Current advances in rna therapeutics for human diseases. Int J Mol Sci，2022，23(5): 2736.

BONNEAU E， NEVEU B， KOSTANTIN E， et al. How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. EJIFCC，2019，30(2): 114–127.

DIENER C， KELLER A， MEESE E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet，2022，38(6): 613–626.

YU M， HUANG J， ZHU T， et al. Liraglutide-loaded PLGA/gelatin electrospun nanofibrous mats promote angiogenesis to accelerate diabetic wound healing via the modulation of miR-29b-3p. Biomater Sci，2020， 8(15): 4225–4238.


Refbacks

  • There are currently no refbacks.